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IN 1930-shortly after his death-a book written by von Pirquet was pub-
lished. This treatise gave an analysis of the age distribution of a large number
of malignant tumours, the mortality statistics having been obtained from the
British Registrar-General.
One of the interesting facts presented was a bimodal type of age distribution
of mammary carcinoma: it was shown that the distribution was probably built
up by two separate distributions, one having its highest frequency at about 50
years of age, the second type (a
" Spiitkrebs ") being most frequent at about 70
years.
After World War 11 attention to this peculiar feature was drawn again by
Jacobsen (1946) and by Clemmesen (1948) who had been working with morbidity
figures of the Danish Cancer Registration. From many sides confirmation of
the bimodal type of age distribution was published: Anderson et al. (1950) gave
morbidity figures from Connecticut, U.S.A., Maisin and Langerock (1955) pre-
sented graphs of Danish, Swedish and French material at the Congress of Geo-
graphicalPathologyheld atWashington ; at thePerugiaSymposium on mammary
cancer Denoix (1958) showed the French data in full, while Desaive, Lavigne
-and Adrianne (1958) gavefigures from Belgium. Further confirmation came from
Ficke and Reiszig (1958) from the German Democratic Republic and from
Pedersen and Magnus (1959), the latter paper being an official publication of the
Norwegian Cancer Registry.
In the material of the Dutch Cancer Registry we found a bimodal type of age
distribution too. Fig. la shows an age specific frequency curve of morbidity,
and Fig. lb presents an age specific curve of mortality, computed from data of
the Central Bureau of Statistics. These curves run upwards steeply but show a
diminution of this trend between the 45th and 55th year, namely in the period
of onset of the menopause. This phenomenon could be interpreted by assuming
that at menopausal age the curve of the fi-rst kind of mammary cancer (that of
reproductive age) decreases sharply, while the curve of the second kind (the
" Spiitkrebs ") has not increased so much that it already compensates for that
decrease.
However, the typical bimodal age distribution is not found in every statistical
material. The figures of Phillips and Owchar (1957) from eight countries are
not considered here, because they have been related to a standard population
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from abroad (Canada). But the curves which can be constructed with the
figures of Stocks (1959) show that in the metropolitan areas of the U.S.A. no
significant retardation of the steeply increasing curve of age specific morbidity
is seen between the age of 45 and 55 years, in contrast to the Scandinavian
countries (Fig. 2). We shall return to a possible explanation of this fact later.
Several authors have been wondering what this bimodal age distribution
actually means. Can we speak of two types of mammary cancer? And in
which respect do these types differ ? Is their cause also different ?
AGE
FIG. la.-Age-specific morbidity (per 100,000 women) of mammary carcinoma in the Nether-
lands. 3081 cases diagnosed during 1957 and 1958 and coRected by the Central Cancer
Registry, Amsterdam. It is estimated that about 70 per cent of aR cancers are being registered at present; no correction for this has been attempted. Population figures
supplied by the Central Bureau of Statistics, The Hague (population at December 31,
1956).
Maisin and Langerock (1955) made some suggestions as to the nature of the
two types. They mentioned inter alia that from animal experiments evidence
had been obtained that in the genesis of mammary cancer of older age an adrenal
dysfunction played a part. Their compatriots Desaive, Lavigne and Adrianne
(1958) went a step further at the Perugia Symposium, postulating without any
reserve that the type of mammary carcinoma of reproductive life was due to a
dysfunction of the ovaries, and the postmenopausal type to a dysfunction of the
adrenals.
Ficke and Reiszig (1958) were more cautious, but they too drew attention to
the decreasing incidence of the younger type of mammary cancer when the439 AGE DISTRIBUTION OF MAMMARY CARCINOMA
oestrogen production by the ovaries ceases. The curve of the older patients
should be the result of a compensating oestrogen production by other endocrine
glands. It is known that the adrenals may produce these substances.
Such ahypothesis is not unattractive, for animalexperiments have shown that
oestrogens-although physiological substances-may under certain conditions
have a carcinogenic effect on the mammary gland (Miihlbock and Boot, 1959).
AGE
FiG. lb.-Age-specific mortality (per 100,000 women) of manunary carcinoma in the Nether-
lands. 3191 death certificates registered during 1957 and 1958 by the Central Bureau of
Statistics, The Hague. N.B. : It is for the greater part about other women than in the
graph of morbidity. The anomaly in the curve between 45 and 55 years is less than in
the curve of Fig. la probably due to the longer and inconstant period between onset and
registration of the malignancies.
In laboratory animals early bilateral adrenalectomy is equally effective as early
castration inlowering the incidence ofspontaneous mammary carcinoma (Shimkin
andWyman, 1945). There are many indications that thetherapeutic significance
of bilateral ovariectomy and adrenalectomy is based on the elimination of oestro-
gens. If it should be possible to distinguish by clinical or laboratory means
between ovarian and adrenal oestrogens the hypothesis could be tested that the
two types of mammary cancer may be related to a dysfunction of the ovaries and
the adrenals respectively.
Cytological work of Bruinsma and de Waard (1959) seems to enable us to
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logical considerations concerning endometrial cancer, wondered whether post-
menopausal oestrogen production perhaps would occur in patients with diabetes
mellitus, obesity and essential hypertension. A group of 42 diabetics showed
indeed a significant higher number ofvaginal smears characteristic ofoestrogenic
activity than did a control group. The difference between these groups was
owing to the diabetic patients with obesity and/or hypertension. In the case of
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per 100,000 women, after FiG. 2.-Age specific morbidity of manunary carcinoma per year
Stocks (1959, Table 4).
patients with obesity and/or hypertension without diabetes oestrogenic smears
were frequently encountered too. Because of the limited number of diabetic
patients withoutobesity orhypertension it wasimpossible to draw any conclusions
about a possible difference between these patients and the control group. Of
significance were thefindings ofoestrogenic smears in 17 castrated diabetics. The
authors concluded that the oestrogens responsible for these effects were probably
of adrenal origin.
De Waard and Baanders (to be published) made acytological investigation of
the urinary sediments of more than I00 women over 55 years of age from the
population ofUtrecht, Holland, who had been invited to serve as a normal control
group in a genetic investigation. There exists a cytological parallelism between441 AGE DISTRIBUTION OF MAMMARY CARCINOMA
thevaginal smear and theurinary sediment (Lencioni, 1953), permitting endocrine
evaluation of the latter after staining with Shorr's trichrome stain. The results
of this investigation confirmed and completed those of Bruinsma and de Waard
(1959) by showing clearly the influence of hypertension and obesity on the
frequency of oestrogenic pictures in women with ovaries as well as in those
without. Moreover, a study was made of glucose tolerance in the non-obese,
non-hypertensive subjects. It was shown that the few women of this subgroup
presenting a certain oestrogenic activity had a decreased glucose tolerance. The
authors concluded that the combined groups of postmenopausal women with
obesity, hypertension and a decreased glucose tolerance contained all those
exhibiting oestrogenic activity cytologically. This condition of continuous
hormonal activity was called: adrenal oestrus.
PLAN OF STUDY. MATERIAL AND METHOD
Based on this cytological evidence for adrenal oestrus and on the epidemio-
logical fact of a bimodal age distribution of mammary cancer the following plan
ofstudy was made:
Of a number of patients with mammary carcinoma we investigated
Weight and height.
Blood pressure.
Glucose tolerance.
If obesity, hypertension or a decreased glucose tolerance were present it was
assumed that adrenal oestrogen would have been present which could have
promoted thecarcinogenesis in the mammarygland. If none ofthesepathological signs was found it was supposed that any carcinogenic influence of oestrogens would have come from the ovaries. Ofthe
" adrenal
" as well as ofthe
" ovarian
"
type of patients with mammary cancer an age distribution could be made ; if
these age distributions coincided with the distributions found by epidemiologists in their morbidity statistics an argument would be provided for the correctness
of the hypothesis.
The material obtained from 108patients was collected in six differenthospitals. The patients belonged for the greater part to the population of two large towns.
Only cases of recent onset (less than six months between first diagnosis and our
investigation) in which the malignancy had been confirmed by the pathologist
were studied. Cases with distant metastases and those who were or had been
treated endocrinologically (with hormonepreparations orbysurgical intervention)
were omitted.
The criteria for classification according to relative weight, blood pressure and
glucose tolerance were the following: a body weight more than 25 per cent
above Ideal Weight was called obesity; we used the Table of Ideal Weights given by Boe, Humerfelt and Wedervang (1957). In laying down the criteria for
hypertension we evaluated both the systolic and the diastolic pressure. In the
first place the lead given by the Expert Committee on Cardiovascular Disease
and Hypertension ofthe World Health Organisation (1959) was followed, drawing
a dividing-line between normal and abnormal blood pressure at 160/95 mm.
Hg. This dividing-line has been shown by Morrison and Morris (1959) not to be
a purely arbitrary one. However, we considered it justifiable to include as442 DE WAARD, DE LAIVE AND BAANDERS-VAN HALEWIJN
hypertensive cases those with a diastolic pressure of 100 mm. Hg or more if their
systolic pressure was at least 150 mm. Hg, and those with a systolic pressure of
170 mm. Hg or more irrespective of diastolic pressure.
The glucose tolerance tests were carried out either pre-operatively or more
than 14 days post-operatively in order to avoid the effect ofsurgical stress. The
amount ofglucose given was 50 g. by mouth; the blood sugar estimations were
performed in 73 cases according to the method of Hagedorii and Jensen and in
35 according to Folin and Wu.* In judging the blood sugar curves attentioli
was given to both components composing a diabetic type of curve separately:
1. bloodglucose levelincreasing toomuch, 2. level notdecreasingtooriginal (fasting)
value within 2 or 2.1 hours. Ad 1. we considered the level to be pathological,
if at least two values above 180 mg. per cent or one value above 190 mg. per cent
was reached. Ad 2. we fixed a dividing Iiiie between normal and abliormal after
making frequency distributions of the differei-ice between the 2- or 9'-hour values
ai-id the fasting values. It was seen that also at higher ages a decrease to below
the fasting value often took place, and that a suitable boundary between normal
ai-id abnormal was to be found in the region of 2- or 21-hour levelslying 10-20 mg. 2
per cent above the fasting values. We chose finally as the dividing Iiiie : 20 mg.
per cent above the fasting value, consideriiig curves with differences of 15-12.0 mg.
per cent dubious ones.
RESULTS
Based on the above criteria we divided the patients into two groups : one
without aiiypathological feature ofthetriad-obesity, hypertensioli or a decreased
glucose tolerance, the second with at least one of those features. Three women
who were not obese nor hypertensive, but who exhibited a dubious blood sugar
curve were classified separately in Table I and omitted from Fig. 3 which thus
presents the result of our separatioi-i of 105 cases. In this figure which is a
graphical condensation of Table I two frequency distributions are seen with
modes in the 45-50 and the 60-64 age classes respectively, which show a striking
similarity to the distributions expected by epidemiologists. This doe's not prove
that our hypothesis is correct, but it gives definite support to it.
An important question which has to be investigated is : does one in separating
aiiy female population according to the presence or the absence of obesity,
hypertension and decreased glucose tolerance perhaps find two age distributions
similar to the distribution of mammary cancer patients ? It is well known that
the features of this triad are much more frequent later in life than in the repro-
ductive period.
We have investigated this point with care, making use of data of a statistical-
genetic study designed by two of us (not yet published). The control group
i-ieeded for this study was obtained by taking 1000 cards of women out of the
files of the Population Registry of the town of Utrecht (250,000 inhabitants).
This was done at random apart from a certain age distribution. These womei-I
were invited to an interview about cancer in their families, together with a brief
physical examination including measurement of weight, height, blood pressure
and examination of the urine. Almost 60 per cent of these women co-operated;
* As judged by frequency distributions of the fasting levels the values obtained by the former
method are about 5 mg. per cent lower than those obtained by the latter.AGE DISTRIBUTION OF MAMMARY CARCINOMA 443
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an analysis of their addresses revealed that the living quarters of the higher
educational classes were represented slightly better than the other ones. Making
a comparison with a group of mammary cancer patients this does not seem to
be a draw-back, because it is known that patients with this type of cancer consti-
tute also a slight selection among the higher educational population groups.
The investigation provided us with the data of 571 women. They were
divided into two groups according to the same criteria ofobesity andhypertension
as the 108 patients with mammary cancer (it was impossible to perform a glucose
tolerance test in all of them). In view of the shape of the histograms of Fig. 3
we were interested in the question whether obesity and hypertension (occurring
singly or combined) were more frequent in the postmenopausal cancer patients
than in thepostmenopausal controls. Table 11 shows that this was found indeed.
Within both groups there exist small differences between the age classes which
are, however, far from significant ('y2-test). Thus it is permissible to combine the
different age classes above 55 years and to summarize as follows : in the mammary
cancer group 42 of 59 women are obese and/or hypertensive, that is 71 per cent.
In the control group 174 of 322 women have obesity and/or hypertension, that is
54 per cent. Although this latter percentage is high too, the difference from the
mammary cancer group is significant (hypergeometrical distribution, P < 0-02).
Ifthe criterion forhypertension is modified in such a way thatonly blood pressures
of at least 170 mm. Hg systolic fall into the pathological group, the difference
between the cancer group and the control group becomes evengreater (P < 0-01).
TABLE II.-Reiative Frequency of Obesity and Hypertension (Occurring Singly or
Combined) in Mammary Cancer Patient8 and Controls Over 55 Years ofAge
Age
r
55-59 60-64 65-69 70-74 75-79 80-84 Total
Mammary cancer Number of women 15 16 10 10 4 4 59
group Number of women 9 12 8 8 3 2 42
with obesity
and/or hyper-
tension
Control group Number of women 78 77 67 45 36 19 322
Number of women 40 45 38 21 18 12 174
with obesity
and/or hyper-
tension
Thus the conclusion seems to be justified that mammary carcinoma after the
menopause has a preference for the obese and the hypertensive, occurring almost
exclusively in women with obesity and/or hypertension and/or a decreased
glucose tolerance, conditions which are associated with oestrogenic activity of
adrenal origin.
DISCUSSION
The direct evidence of a connection between adrenal oestrogen production
and a decreased glucose tolerance in older people not yet being amply present,
some indirect evidence may be wanted.445 AGE DISTRIBUTION OF MAMMARY CARCINOMA
It is known that older patients with diabetes mellitus with or without obesity
who do well on a dietary regime alone or in conjunction with oral administratioii
of sulfonylurea derivatives (like tolbutamide, etc.) produce insulin in reasonable
amounts ; their diabetes is considered a
" Gegenregulationsdiabetes
" (Bertram,
Bendfeldt and Otto, 1956). Those who are of the opinion that the adrenals
play a part in this
" Gegenregulation
" (Bastenie, 1956) find support in the
observations of Szenas and Pattee (1959) that the glucocorticoid production in
obesity is increased. This influence ofoverweight is also to be gathered from the
statistical data of Borth, Linder and Riondel (1957). Moreover the decreased
glucose tolerance which is so often found in obese subjects is of the G.I.T.T.-
positive type, pointing to increased secretioii ofglueocorticoids too (Arelidt and
Pattee, 1956).
There exists a certain parallelism between the production of glucocorticoids
and adrenal oestrogens : operative stress or injection of ACTH increases the
urinary excretioii of both types of steroids (De'court et al., 1951 ; Bulbrook et al.,
1958 ; Brown, Falconer and Strong, 1959) and cortisone therapy inhibits the
production not only ofglucocorticoids but also of adrenal oestrogens (Smith and
Emerson, I954; Block, McCarthy and Vial, 1959b).
We are not of the opinion that every curve revealing decreased glucose tolei-
ance is of necessity a reflection of an increased secretion of glucocorticoids (it
would have beeii preferable if also glucose-insulin tolerance tests of our patieiits
could have been made). However, it seems reasonable to assume with Frei-ich
gerontologists that at older age in the larger part of these curves the adren,"d
cortex plays a part (Binet and Bouli'ere, 1955), and such aii assumptioii already
satisfies the epidemiologist.
If our observations can be confirmed by others, a definite perspectiveregarding
mammary cancer is looming up. In the first place the indicatioiis in the treat-
ment of metastasized mammary carcinoma could get a more theoretical basis.
In judging the results of different hormonal kinds of therapy the type of cancer
ovarian
"
or
" adrenal ") could be included in the considerations. Our curve
of the ovarian
" type (Fig. 3) fits well in with the observatioiis of Dao aild
Huggins (1957) that after 54 years of age bilateral o6phorectomy is seldom
ii-idicated. lt could be found that youiig womeii with obesityand/orhypertensioli
are not helped sufficiently by castration aloiie but that in them at aii early stage
the elimination of adrenal oestrogens must be advocated, either by surgical means
or by suppression of pituitary ACTH with corticosteroids. Finally the fact
could be understood why some patients who did not react favourably to surgical
castration were subsequently greatly helped by adrenalectomy (Block et al.,
1959a), the poor castration response not being based oii hormone independeiice
but on the fact that the ovaries were inactive in contrast to the adrenals.
But of no less significance seems to us the possibility for more insight into some
aetiological factors of mammary carcinoma. We venture to present the followiilg hypothesis :
It is well known that heredity and environmeiit play a part in the genesis of
mammary cancer. Concerning the environmental factor(s) it must be stipulated
that this carcinoma has a preference for the higher social classes (Stocks, 19-55)
and that it is seen more frequently in Western countries than in peoples of Asia
and Africa (Segi et al., 1957 ; Oettle' and Higginson, 1958).
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It is also well known that the disease entities of the triad obesity, essential
hypertension and diabetes mellitus (" diab'ete gras ") are more frequent in the
materially blessed peoples of Western countries than in these African and Asian
peoples (de Langen, 1958; Smirk, 1949). Further, obesity, hypertension and
diabetes have also a hereditary aspect.
We suppose that the phenomenon of adrenal oestrus on account of its associa-
tion with obesity, hypertension and decreased glucose tolerance (not only in
statistical but probably also in pathophysiological respect) has also a hereditary
and an environmental aspect, and that these aspects in turn determine the
hereditary and the environmental aspects of the
" adrenal
" type of mammary
carcinoma.
With this hypothesis the peculiar feature shown in Fig. 2 could be explained
why the bimodality of the age-specific frequency curve of mammary cancer is
not pronounced in the metropolitan areas of the U.S.A. in contrast to the
Scandinavian countries. In these parts of the U.S.A. the Western technical
civilization finds its summit, with all the life habits (nutrition inter alia) inherent
to it. If diabetes, obesity and hypertension and the phenomenon of adrenal
oestrus begin to occur a few years earlier in life and if their frequencies increase
with age somewhat stronger than elsewhere in the Western world, the
" adrenal
"
group of mammary cancers will overlap the
" ovarian
" group almost completely
masking the decrease of the latter group at menopausal age.
This environmental aspect of the older type of breast cancer may also explain
certain facts mentioned by McMahon (1957), himself a critic of the bimodal type bypothesis, namelv, (1) the difference inmortality trends during the 20th century between mammary cancer among pre- and postmenopausal women respectively,
(2) the shift in the incidence break of the age specific morbidity curves of breast
cancer in Connecticut, (3) the differences between the curves of Danish urban and
rural areas.
ln contrast to the life habits of Western countries we know of peoples with
ways ofliving in which diabetes, obesity andhypertension arerelatively unknown.
Perhaps by changing our nutritional habits we might be able to reduce not only the incidence ofthese diseases but also that ofadrenal oestrus and ofthe
" adrenal"
type of mammary carcinoma.
SUMMARY
Morbidity and mortality statistics suggest that the population of mammary
cancer patients in Western countries is composed of two populations, each with
its own age distribution having their highest frequencies about 48 years and
65 years of age respectively. Statistics from the Netherlands show this bimodal
distribution too.
In trying to find a possible basis for this phenomenon the hypothesis is dis-
cussed that the type of mammary cancer of reproductive age is caused by an
ovarian dysfunction and the type of older age by an adrenal dysfunction. This
hypothesis is tested by applying epidemiologically the fact established by endo-
crinecytologythatpatients withobesity, essentialhypertensionand/or a decreased
glucose tolerance often show signs ofoestrogenic activity which are veryprobably of adrenal origin.
The results of this application seem to be in agreement with the mentionedAGE DISTRIBUTION OF MAMMARY CARCINOMA 447
hypothesis. The possible significance of these facts for more insight into the
hereditary and the environmental aspects of mammary cancer is discussed.
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belt; A. L. E. Schaepkens van Riempst (Antonius Ziekenhuis, Utrecht) ; A.
Stofberg (Geertruiden Ziekenhuis, Deventer) and Dr. E. Verschuyl. The cancer
morbidity figures were supplied by L. Meinsma, director of the Central Cancer
Registry. Dr. E. Tonkes and Miss N. Vermeulen gave their valuable assistance
in the investigation ofthe control group.
REFERENCES
ANDERSON, E., REED, S. C., HUSEBY, R. A. AND OLIVER, C. P.-(1950) Cancer, 3,
410.
ARENDT, E. C. AND PATTEE, C. J.-(1956) J. clin. Endocrin., 16, 367.
BASTE'NIE, P.-(1956) 'Cortico-surre'nale et diab'ete humain'. Paris (Masson).
BERTRAM, F. , BENDFELDT, E. AND OTTO, H.-(1956) Dt8ch. med. Wschr., 81, 274.
BINET, L. AND BoURLIE'RE, F.-(1955) 'Pre'eis de Ge'rontologie'. Paris (Masson),
p. 479.
BLOCK, G. E., BURGESS VIAL, A., MCCARTHY, J. D., PORTER, C. L. W. AND COLLER,
F. A.-(1959a) Surg. Gynec. 068tet., 108, 651.
Idem, MCCARTHY, J. D. AND BURGESS VIAL, A.-(1959b) Arch. Surg., 78, 732.
BOE, J., HUMERFELT, S. AND WEDERVANG, F.-(1957) Acta med. .8cand., Suppl. 321,
Table 50, p. 145.
BORTH, R., LINDER, A. AND RioNDEL, A.-(1957) Acta endocr., Copenhagen, 25, 33.
BROWN, J. B., FALcONER, C. W. A. AND STRONG, J. A.-(1959) J. Endocrin., 19, 52.
BRLTINSMA, A. H. AND DE WAARD, F.-(1959) Acta endocr., Copenhagen, 32, 233.
BULBROOIK., R. D., GREENWOOD, F. C., HADFIELD, G. J. AND SCOWEN, E. F.-(1958) Brit. med. J., ii. 7.
CLEMMESEN, J.-(1948)-Brit. J. Radiol., 21, 583.
DAO. T. L. AND HUGGINS, C.-(1957) J. Amer. med. A8,9., 165y 1793.
DE'COURT 7 J., JAYLE, M. F., CRE'PY, 0. AND JUDAS, O.-(1951) Ann. d'Endocr., 12,
719.
DENOIX, P. F.-(1958) Proc. 2nd int. Symp. on Mammary Cancer, Perugia, p. 285.
DESAIVE, P., LAVIGNE, J. AND ADRIANNE, A.-(1958) Ibid., p. 37.
IFICKE, K. H. AND REISZIIG, G.-(1958) Arch. Geschwul8tforsch., 12, 379.
JACOBSEN, O.-(1946) 'Heredity in breast cancer. London (Lewis & Co.).
DE LANGEN, C. D.-(]958) Geneesk. Bl., 48, No. 3.
LENCIONI, L. J.-(1953) J. clin. Endocrin., 13, 263.
MCMAHON, B.-(1957) Cancer, 10, 1037.
MAISIN, J. H. AND LANGEROCK, G.-(1955) Schweiz. Z. Path., 18, 690.
MORRISON, S. L. AND MORRIS, J. N.-(1959) Lancet, ii, 864.
MtHLBOCK, 0. AND BOOT, L. M.-(.1959) Ciba Foundation Symposium on Carcino-
genesis. London (Churchill), p. 83.
OETTLE', A. G. AND HiGGiNSON, J.-(1958) Proc. 2nd int. Symp. on Mammary Cancer,
Perugia, p. 203.
PEDERSEN, E. AND MAGNUS, K.-(1959) Cancer Registration in Norway, Monograph No. I of the Norwegian Cancer Society.
PHILLIPS, A. J. AND OWCHAR, M.-(1957) Bull. World Hlth Org., 16, 267.448 DE WAARD, DE LAIVE AND BAANDERS-VAN HALEWIJN
VON PMQUET, C.-(1930) 'Allergie des Lebensalters: die b6sartigen Geschwiilste'.
Leipzig (Thieme Verlag).
SEGI) M., FT-TiKuSHIMA, I., FT-TjisAKu, S., KUZIHARA, M., SAITO, S., ASANO, K., NAGAIKA,
H., NoYE, Y. AND YAmoi, M.-(1957) J. nat. Cancer Inst., 18, 373.
SMMKIN, M. B. AND WYMAN, R. S.-(1945) Ibid., 6, 187.
SMITH, 0. W. AND EMERSON, K.-(1954) Proc. Soc. exp. Biol. N.Y., 85, 264.
SmiRK, F. H.-(1949) Brit. med. J., i, 791.
STOCKS, P.-(1955) Schweiz. Z. Path., 18, 706.-(1959) Bull. World. Hlth Org., 20,
697.
SZENAS, P. AND PATTEE, C. J.-(1959) J. clin. Endocrin., 19, 344.
DE WAARD, F. AND BAANDERS, E. A.-To be published .a Acta Endocr., Copenhagen.
WORLD HEALTH ORGANISATION.-(1959) Tech. Rep. Ser. No. 168.